The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, D. B.
Right arrow Articles by Hozumi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, D. B.
Right arrow Articles by Hozumi, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

The Journal of Immunology, Vol 151, Issue 7 3627-3637, Copyright © 1993 by American Association of Immunologists

ARTICLES

Characterization of the insulin A-chain major immunogenic determinant presented by MHC class II I-Ad molecules

DB Williams, J Ferguson, J Gariepy, D McKay, YT Teng, S Iwasaki and N Hozumi
Samuel Lunenfeld Research Institute Mount Sinai Hospital, Department of Immunology, University of Toronto, Ontario, Canada.

Data are presented which demonstrate the minimal insulin peptide required to activate a large group of insulin-specific T hybrids following presentation by either live or fixed APC, is the N-terminal insulin-A(1-13) peptide. Functional activation and competition assays using both live and fixed APC with 19 synthesized variants of the N- terminal bovine insulin A-chain molecule permitted classification of peptide residues into MHC agretope and T cell epitope regions. Our findings indicate insulin A-chain peptide occupies the Ag binding groove of class II MHC in an extended conformation as a result of intracellular reduction of A-loop disulfide bonds. Insulin A-chain Cys7 and Cys11 residues represent two independent T cell epitopes N- and C- terminal to the A-loop region. Data are presented that demonstrate the unique residues associated with several insulin isoform molecules contribute to the peptide agretope region. Our findings may suggest peptide agretopes may subtly modify the peptide/MHC conformation presented to TCR.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. A. Haque, J. W. Hawes, and J. S. Blum
Cysteinylation of MHC Class II Ligands: Peptide Endocytosis and Reduction Within APC Influences T Cell Recognition
J. Immunol., April 1, 2001; 166(7): 4543 - 4551.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. P. Thayer, J. R. Kraft, S. M. Tompkins, J. C. Moore IV, and P. E. Jensen
Assessment of the Role of Determinant Selection in Genetic Control of the Immune Response to Insulin in H-2b Mice
J. Immunol., September 1, 1999; 163(5): 2549 - 2554.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. E. Wither and B. Vukusic
The Orientation and Nature of the Interaction Between Beef Insulin-Specific TCRs and the Insulin/Class II MHC Complex
J. Immunol., February 15, 1999; 162(4): 2113 - 2122.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. A. Ettinger and W. W. Kwok
A Peptide Binding Motif for HLA-DQA1*0102/DQB1*0602, the Class II MHC Molecule Associated with Dominant Protection in Insulin-Dependent Diabetes Mellitus
J. Immunol., March 1, 1998; 160(5): 2365 - 2373.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.